NYSE:EW
Edwards Lifesciences Corporation
- Stock
Last Close
82.44
06/11 21:10
Market Cap
56.51B
Beta: 1.01
Volume Today
3.88M
Avg: 3.25M
PE Ratio
36.59
PFCF: 66.37
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 302.85M - | 318.35M 5.12% | 368.25M 15.67% | 475.75M 29.19% | 580.95M 22.11% | 623.95M 7.40% | 721.60M 15.65% | 764.50M 5.95% | 801.10M 4.79% | ||
average payables | 53.30M - | 61.05M 14.54% | 80.50M 31.86% | 106.85M 32.73% | 125.30M 17.27% | 157.20M 25.46% | 188.45M 19.88% | 200.50M 6.39% | 203.20M 1.35% | ||
average receivables | 326.50M - | 334.55M 2.47% | 379.35M 13.39% | 438.40M 15.57% | 499.75M 13.99% | 568.20M 13.70% | 600.95M 5.76% | 633.85M 5.47% | 682M 7.60% | ||
book value per share | 3.43 - | 3.87 12.90% | 4.10 5.86% | 4.73 15.48% | 5.00 5.72% | 6.64 32.69% | 7.35 10.66% | 9.36 27.44% | 9.38 0.19% | ||
capex per share | -0.15 - | -0.16 12.34% | -0.34 106.53% | -0.28 18.47% | -0.39 38.84% | -0.45 15.70% | -0.65 46.82% | -0.53 19.12% | -0.43 19.15% | ||
capex to depreciation | -1.37 - | -1.62 18.50% | -3.05 88.65% | -2.14 29.82% | -3.12 45.73% | -3.12 0.17% | -3.80 21.87% | -2.45 35.61% | -1.90 22.47% | ||
capex to operating cash flow | -0.09 - | -0.19 111.38% | -0.31 59.30% | -0.18 43.18% | -0.26 48.70% | -0.24 9.49% | -0.39 63.66% | -0.19 50.71% | -0.22 14.16% | ||
capex to revenue | -0.04 - | -0.04 5.88% | -0.07 71.76% | -0.05 30.36% | -0.06 27.09% | -0.06 1.38% | -0.09 45.02% | -0.06 32.12% | -0.05 21.95% | ||
cash per share | 2.25 - | 1.89 15.87% | 1.99 5.01% | 2.11 6.27% | 1.52 27.90% | 2.43 59.30% | 2.25 7.21% | 2.35 4.46% | 1.96 16.57% | ||
days of inventory on hand | 173.16 - | 201.01 16.08% | 181.54 9.69% | 231.39 27.46% | 235.85 1.92% | 209.91 11.00% | 271.00 29.10% | 212.38 21.63% | 295.78 39.27% | ||
days payables outstanding | 33.96 - | 37.79 11.29% | 44.45 17.62% | 48.62 9.40% | 52.07 7.08% | 59.09 13.49% | 66.37 12.33% | 59.77 9.95% | 68.21 14.13% | ||
days sales outstanding | 51.07 - | 50.37 1.37% | 51.06 1.38% | 49.11 3.82% | 52.68 7.27% | 50.29 4.53% | 50.16 0.26% | 46.38 7.54% | 47.41 2.22% | ||
debt to assets | 0.17 - | 0.15 12.92% | 0.18 23.37% | 0.18 0.21% | 0.11 38.69% | 0.10 6.20% | 0.10 8.22% | 0.08 15.45% | 0.08 2.68% | ||
debt to equity | 0.27 - | 0.24 12.19% | 0.31 31.01% | 0.35 10.22% | 0.19 45.36% | 0.16 13.46% | 0.15 7.16% | 0.12 22.14% | 0.12 0.65% | ||
dividend yield | 0.02 - | 0.00 88.94% | 0.01 588.49% | 0.02 - | 0.00 98.19% | ||||||
earnings yield | 0.06 - | 0.03 51.37% | 0.03 1.87% | 0.03 8.28% | 0.02 13.88% | 0.02 4.40% | 0.01 32.72% | 0.02 28.41% | 0.03 77.03% | 0.03 8.01% | |
enterprise value | 13.51B - | 16.90B 25.10% | 19.85B 17.45% | 23.99B 20.85% | 31.92B 33.08% | 48.09B 50.63% | 56.31B 17.11% | 80.58B 43.09% | 46.11B 42.78% | ||
enterprise value over ebitda | -76.37 - | 26.01 134.06% | 22.42 13.82% | 24.00 7.06% | 22.96 4.33% | 36.14 57.37% | 32.44 10.22% | 54.32 67.43% | 25.20 53.62% | ||
ev to operating cash flow | 13.22 - | 30.75 132.66% | 28.18 8.35% | 23.97 14.93% | 34.44 43.69% | 40.77 18.37% | 53.41 31.00% | 46.52 12.90% | 37.85 18.64% | ||
ev to sales | 5.82 - | 6.78 16.53% | 6.70 1.18% | 6.98 4.26% | 8.57 22.80% | 11.06 28.97% | 12.84 16.08% | 15.40 19.95% | 8.57 44.37% | ||
free cash flow per share | 1.45 - | 0.69 52.83% | 0.76 11.17% | 1.30 71.13% | 1.09 16.30% | 1.44 32.10% | 1.04 27.94% | 2.25 116.50% | 1.54 31.54% | 0.01 99.44% | |
free cash flow yield | 0.07 - | 0.03 61.96% | 0.02 6.29% | 0.03 42.27% | 0.02 38.41% | 0.02 13.27% | 0.01 38.57% | 0.02 52.46% | 0.02 18.87% | 0.00 99.46% | |
graham net net | 0.78 - | 0.15 80.84% | -0.17 215.98% | -1.17 575.62% | -0.83 29.13% | -0.09 89.74% | -0.65 668.73% | -0.54 17.07% | -0.50 8.08% | ||
graham number | 9.90 - | 8.17 17.49% | 9.07 11.02% | 10.23 12.87% | 11.38 11.23% | 15.82 39.00% | 14.79 6.54% | 22.54 52.44% | 22.78 1.07% | ||
income quality | 1.26 - | 1.11 11.87% | 1.24 11.36% | 1.71 38.63% | 1.28 25.16% | 1.13 12.21% | 1.28 13.66% | 1.15 10.00% | 0.80 30.54% | ||
intangibles to total assets | 0.11 - | 0.21 81.23% | 0.18 10.30% | 0.28 51.93% | 0.27 2.33% | 0.23 15.20% | 0.21 10.33% | 0.18 15.62% | 0.17 0.35% | 0 100% | |
interest coverage | 44.69 - | 69.11 54.65% | 93.31 35.02% | 352.66 277.94% | -356.29 201.03% | 55.40 115.55% | 103.06 86.03% | 73.29 28.89% | 91.07 24.26% | ||
interest debt per share | 0.95 - | 0.94 1.11% | 1.30 37.96% | 1.64 26.36% | 0.94 42.60% | 1.12 18.75% | 1.14 1.96% | 1.14 0.39% | 1.15 0.95% | ||
inventory turnover | 2.11 - | 1.82 13.85% | 2.01 10.73% | 1.58 21.55% | 1.55 1.89% | 1.74 12.35% | 1.35 22.54% | 1.72 27.60% | 1.23 28.19% | ||
invested capital | 0.27 - | 0.24 12.19% | 0.31 31.01% | 0.35 10.22% | 0.19 45.36% | 0.16 13.46% | 0.15 7.16% | 0.12 22.14% | 0.12 0.65% | ||
market cap | 13.57B - | 17.02B 25.46% | 19.96B 17.26% | 23.77B 19.10% | 32.04B 34.80% | 48.59B 51.63% | 56.80B 16.90% | 80.75B 42.16% | 46.18B 42.81% | 46.26B 0.17% | |
net current asset value | 961.70M - | 491.70M 48.87% | 349M 29.02% | -169.70M 148.62% | 103.60M 161.05% | 644.20M 521.81% | 428.20M 33.53% | 514M 20.04% | 610M 18.68% | ||
net debt to ebitda | 0.31 - | -0.18 157.93% | -0.12 33.25% | 0.22 279.24% | -0.09 139.66% | -0.38 334.47% | -0.28 25.17% | -0.12 58.66% | -0.04 63.49% | ||
net income per share | 1.27 - | 0.77 39.69% | 0.89 16.42% | 0.98 10.32% | 1.15 17.03% | 1.68 45.61% | 1.32 21.07% | 2.41 82.34% | 2.46 1.95% | 2.31 5.98% | |
operating cash flow per share | 1.60 - | 0.85 46.85% | 1.10 29.65% | 1.58 43.48% | 1.48 6.63% | 1.89 27.83% | 1.69 10.29% | 2.78 64.10% | 1.97 29.18% | 0.01 99.56% | |
payables turnover | 10.75 - | 9.66 10.14% | 8.21 14.98% | 7.51 8.59% | 7.01 6.61% | 6.18 11.88% | 5.50 10.98% | 6.11 11.05% | 5.35 12.38% | ||
receivables turnover | 7.15 - | 7.25 1.39% | 7.15 1.36% | 7.43 3.98% | 6.93 6.78% | 7.26 4.75% | 7.28 0.26% | 7.87 8.15% | 7.70 2.17% | ||
research and ddevelopement to revenue | 0.15 - | 0.15 2.99% | 0.15 2.64% | 0.16 7.54% | 0.17 3.90% | 0.17 3.58% | 0.17 0.18% | 0.17 0.48% | 0.18 1.75% | 0.18 1.64% | |
return on tangible assets | 0.26 - | 0.15 40.89% | 0.15 0.89% | 0.15 2.03% | 0.19 23.10% | 0.21 12.51% | 0.14 31.62% | 0.21 49.26% | 0.22 3.74% | ||
revenue per share | 3.64 - | 3.86 6.11% | 4.64 20.24% | 5.43 17.07% | 5.93 9.25% | 6.96 17.32% | 7.05 1.24% | 8.39 19.16% | 8.70 3.58% | 9.90 13.83% | |
roe | 0.37 - | 0.20 46.58% | 0.22 9.98% | 0.21 4.47% | 0.23 10.70% | 0.25 9.74% | 0.18 28.67% | 0.26 43.08% | 0.26 1.76% | ||
roic | 0.12 - | 0.16 34.27% | 0.18 6.73% | 0.15 13.24% | 0.19 24.62% | 0.21 10.26% | 0.27 30.00% | 0.18 33.97% | 0.23 26.96% | ||
sales general and administrative to revenue | 0.37 - | 0.34 7.64% | 0.31 10.52% | 0.29 6.10% | 0.29 2.00% | ||||||
shareholders equity per share | 3.43 - | 3.87 12.90% | 4.10 5.86% | 4.73 15.48% | 5.00 5.72% | 6.64 32.69% | 7.35 10.66% | 9.36 27.44% | 9.38 0.19% | ||
stock based compensation to revenue | 0.02 - | 0.02 3.76% | 0.02 4.06% | 0.02 6.60% | 0.02 6.36% | 0.02 1.96% | 0.02 12.90% | 0.02 1.05% | 0.02 12.78% | ||
tangible asset value | 1.79B - | 1.67B 6.84% | 1.79B 7.11% | 1.40B 21.69% | 1.69B 20.34% | 2.64B 56.92% | 3.07B 16.10% | 4.34B 41.53% | 4.36B 0.29% | ||
tangible book value per share | 2.80 - | 2.58 7.92% | 2.80 8.37% | 2.21 20.91% | 2.68 21.32% | 4.23 57.62% | 4.93 16.51% | 6.97 41.37% | 7.04 0.99% | ||
working capital | 1.86B - | 1.57B 15.51% | 1.71B 8.64% | 1.13B 33.66% | 1.41B 24.51% | 2.08B 47.60% | 2.20B 5.55% | 2.15B 2.22% | 2.07B 3.49% |
All numbers in USD (except ratios and percentages)